# Stem Cell Therapy for Chronic Kidney Disease

> **NCT04869761** · PHASE1 · COMPLETED · sponsor: **LaTonya J. Hickson** · enrollment: 10 (actual)

## Conditions studied

- Chronic Kidney Diseases
- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Type 1
- Diabetes Mellitus
- Diabetic Nephropathies

## Interventions

- **DRUG:** Allogeneic adipose-derived mesenchymal stem cells (MSC)-Single Infusion
- **DRUG:** Allogeneic adipose-derived mesenchymal stem cells (MSC)-Two Infusions

## Key facts

- **NCT ID:** NCT04869761
- **Lead sponsor:** LaTonya J. Hickson
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-07
- **Primary completion:** 2023-04-26
- **Final completion:** 2023-04-26
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2025-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04869761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04869761, "Stem Cell Therapy for Chronic Kidney Disease". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT04869761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*